Interpreting rapid diagnostic test (RDT) for Plasmodium falciparum
Rapid diagnostic tests have been of tremendous help in malaria control in endemic areas, helping in diagnosis and treatment of malaria cases. It is heavily relied upon in many endemic areas where microscopy cannot be obtained. However, caution should be taken in the interpretation of its result in clinical setting due to its limitations and inherent weakness. This paper seeks to present the varying malaria RDT test results, the possible interpretations and explanation of these results common in endemic regions. Published works on malaria RDT studies were identified using the following search terms “malaria RDT in endemic areas”, “Plasmodium falciparum and bacterial coinfection” “Plasmodium falciparum RDT test results in children in endemic areas” in Google Scholar and PubMed.
The review results show that RDT positive results in febrile patients can either be true or false positive. True positive, representing either a possible single infection of Plasmodium or a co-infection of bacteria and P. falciparum. False RDT negative results can be seen in febrile patient with P. falciparum infection in prozone effect, Histidine rich protein 2 (HRP2) gene deletion and faulty RDT kits. Hence, a scale up of laboratory facilities especially expert microscopy and other diagnostic tools is imperative.
KeywordsRapid diagnostic tests (RDT) Malaria diagnosis Plasmodium falciparum histidine rich proteins-2 (HRP2) Parasite lactose dehydrogenase enzyme (pLDH)
World Health Organization
Integrated Management of Childhood Illness
Rapid Diagnostic Test
Histidine Rich Proteins-2 (HRP2)
Parasite Lactose Dehydrogenase Enzyme
Prompt and accurate malaria diagnosis is important to malaria control programs in endemic regions as it limits over diagnosis as well as provide evidence of infection that requires prompt and adequate treatment . In 2010 for instance, the World Health Organization (WHO) revised the malaria management component of its Integrated Management of Childhood Illness (IMCI) program to an evidence based program of test, treat and track . This is because, the IMCI program formerly recommended that children presenting with fever in malaria endemic regions be treated promptly with anti-malarials [1, 3]. This recommendation was hinged on two main reasons; the first being the limited parasitological diagnostic tools in resource constrained endemic regions and the second being the high prevalence of morbidity and mortality of clinical malaria infections among children in endemic regions [1, 3]. The World Health Organization fully aware of this malaria diagnostic challenge common in endemic regions collaborated with manufactures, scientists and clinicians in the development and introduction into clinical practice a rapid, easy to read and accurate diagnostic test in 2010 [4, 5]. Hence, rapid diagnostic test (RDT) was introduced into clinical management of malaria and since then, more than one million RDTs are used yearly in various health facilities in malaria endemic areas [6, 7]. Although RDT can be used alone in areas where there is no microscopy, it is ideally not meant to replace microscopy which is the gold standard for diagnosis, but rather to complement it [8, 9].
Rapid diagnostic test kits, commonly used in most health facilities in endemic areas include those specific for Plasmodium falciparum histidine rich proteins-2 (HRP2) from SD Bioline Malaria Ag Pf® (Standard Diagnostics, Kyonggi, Korea) and First Response Malaria Ag Pf ® (Premier Medical Corporation Ltd, India) . Other less commonly used ones include CareStart Malaria pLDH/HRP2 combo™ (AccessBio Inc., NJ, USA) and Acon Malaria pLDH/HRP2. Comparison studies have shown that there is not much significant difference between HRP2 and pLDH in terms of their effectiveness in detecting malaria parasites . Rapid diagnostic tests employ lateral flow immunochromatographic assay methods in malaria antigens detection. This involves antigen–antibody interactions on a nitrocellulose test strip [11, 12].
Although, malaria RDTs are of tremendous help, a number of studies have highlighted some weaknesses of the test kits. It is therefore important to highlight the varying presentations of RDTs results, and the possible interpretation and explanations. Hence, this paper seeks to present the varied malaria RDT test results common in endemic regions and provide interpretations for these diverse test results by reviewing various published literature on the subject.
A review of published research work was used to present the diverse malaria RDT test results, provide possible causes and interpretations of the test outcomes. The search words used were “Plasmodium falciparum RDT test results in children in endemic areas”, “Malaria RDT in endemic areas”, “Plasmodium falciparum and bacterial coinfection” and “Asymptomatic plasmodium falciparum in children”. Google scholar and PubMed were the databases used to identify the review documents.
Interpreting RDT results
One of the challenges of the RDT, is the interpretation of the results, especially when compared with microscopy [10, 13]. There are instances where RDT will be positive but no parasites will be seen on microscopy, conversely, there are instances where RDT will be negative but microscopy will detect parasites in the blood . There are instances too, when RDT will be positive but there is no clinical malaria or, the fever is not caused by malaria . Despite the fact that RDTs have been recommended as a means of laboratory confirmation of malaria before the prescription of antimalarial, the interpretation of test results should be done with caution to ensure better clinical outcome in patient management [12, 13, 14].
RDT positive in a patient with fever
There is also another possibility where the fever is indeed caused by P. falciparum infection together with a bacteria, making it a malaria and bacteria co-infection, which is another common presentation in malaria endemic area (Fig. 2) [16, 17, 18]. False positive in a patient with fever is also a possibility  and have been reported in patients with hepatitis C, dengue virus and Toxoplasma gondii infections (Fig. 2) [19, 20]. Immunologic cross-reaction from heterophile antigens produced by these pathogens have been implicated as the cause of these false positive results .
RDT negative in a patient with fever
Antimalarial treatment is not recommended in RDT negative patient with fever, as per the current malaria treatment protocol, such fevers are considered not to be caused by malaria. However, cases of false negative have been reported in patient with high parasite densities, a phenomenon called the prozone effect (Fig. 2) . The prozone effect, also called the high dose-hook phenomenon is caused by excess parasite antigens binding with antigen detecting antibody with no epitope available for capture or test band antibody, to produce the test band result .
Genetic variation of P. falciparum HRP2 have also been implicated in some cases of false negative RDT (Fig. 2) [22, 23]. Reports show that HRP2 gene deletion in endemic areas, lead to absence of HRP2 antigens causing negative result with RDT . However WHO, making a pronouncement on the issue of HRP2 genetic causing false negative RDT result, stated that HRP2 gene deletion might not be the main cause of false negative but rather malfunctioning RDTs due to poor storage and transport condition, operator errors and poor quality RDTs .
False negative can also occur at low parasite densities defined as < 100 asexual parasites/micro liter of blood or < 0.002% of red blood cells infected (Fig. 2) . It is argued that low parasitaemia that is missed by RDT is usually of no clinical significant especially in adult . However, care should be taken in infants and young children with fever and negative RDTs because their rudimentary immunity can allow low parasite density (undetected by RDT) to cause fever (Fig. 2) . However, studies have shown that it is safe to withhold anti malaria from febrile infants and young children with negative RDT [26, 27].
RDT negative result in a patient with fever, have given rise to another nagging problem of over prescription of antibiotics [28, 29]. The main explanation for this is that the health worker assumes that a major non malaria cause of fever is probably a bacterial infection . The interpretation and subsequent decision to give antibiotics to a febrile patient with negative RDT, might not be entirely wrong . However, it is also possible that these patients might have only needed antipyretics  instead of antibiotics since some fevers can be caused by viruses [31, 32].
RDT positive in a patient without fever
Positive RDT results without fever can also occur in patients recovering from malaria after treatment (Fig. 3) . This is because despite successful parasite clearance there can be persistent circulating HRP2 antigens in the blood [38, 39]. These antigens can persists weeks after treatment resulting in positive result, wrong diagnosis and unnecessary treatment of malaria, defeating the whole aim of RDT which is to prevent misdiagnosis and treatment [38, 40].
In some situations, there might not be any parasite or antigens at all in the person’s blood stream and RDT will still be positive. Certain non-fever causing diseases can produce heterophile antigens that can react with test kits antibodies to produce a false positive results . False positive results can arise from disease like Chagas diseases, leshmaniasis, trypanosomiasis and patients with rheumatoid factor (Fig. 3) [19, 20, 21].
RDT negative in a patient without fever
A patient without fever and testing negative for malaria with RDT is most likely free from malaria. However, if they are asymptomatic, their true status will evade RDT especially if the parasite density is very low (Fig. 3) . It will be appropriate not to treat patient with negative RDT especially when afebrile. But again, cases have been reported where health workers treat patients with anti malarials, although they tested negative for RDT and are afebrile, thereby showing a total disregard of the negative RDT result .
The introduction of RDTs have reduced over prescription and indiscriminate use of antimalarial in endemic areas. However, RDT may be flawed by some weakness in estimating parasite densities and inability to detect parasites at low densities. Furthermore, its inability to differentiate between the exact causes of fever in patients with malaria and bacterial infection or other fever causing pathogens has made it dicey in managing febrile patients with antimalarial alone. There is also the problem of false positive results from diseases that produce heterophile antigens and false negative from, prozone effect, HRP2 gene deletion and poor quality RDT.
These weaknesses in malaria RDT kits shows that it cannot solve all the problems of malaria diagnosis in endemic areas. The success of RDT cannot drown the nagging need of a scale up of laboratory facilities in resource limited settings. Expert microscopy should be the goal, together with other necessary laboratory tools to aid in the overall diagnosis of febrile and afebrile patients in malaria endemic areas.
Limitations of the study
Two search engines were used for this review and the researchers acknowledge that it limited the number of studies identified with the subject of interest. This notwithstanding, the articles retrieved present a valid reasoning on the need to be circumspect in the interpretation of RDT test results in endemic regions.
OVN conceptualized, designed and together with VFD searched for the review articles, read through, analyzed and interpreted them. OVN further wrote the first draft of the manuscript and designed the figures. VFD read the draft manuscript and revised it for important intellectual content as well as formatted the figures. AS, edited the figures and also read through the manuscript, providing intellectual input. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Availability of data and materials
Consent for publication
Ethics approval and consent to participate
This research did not receive funding from an external source, it was self-financed by the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 2.World Health Organization. \tWHO: guideline for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010. Nature. 2010;284. http://www.who.int.
- 7.World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015. p. 71–88.Google Scholar
- 10.Dozie U, Chukwuocha U. Comparative evaluation of malaria rapid diagnostic test kits commercially available in parts of south eastern Nigeria. J Trop Dis. 2016;04(02). https://doi.org/10.4172/2329-891X.1000201, http://www.esciencecentral.org/journals/comparative-evaluation-of-malaria-rapid-diagnostic-test-kits-commercially-available-in-parts-of-south-eastern-nigeria-2329-891X-1000201.php?aid=69768.
- 11.World Health Organization. Malaria RDTs—mechanism of action—WHO Western Pacific Region; 2005.Google Scholar
- 23.Muzamil AH, AwadElgeid M, Nasr A. Gene variation and suspected Plasmodium falciparum histidine-rich protein 2 gene deletion and its impact on sensitivity of malaria rapid diagnostic testing in Sudan. BMJ Global Health. 2017;2(Suppl 2):2017–8.Google Scholar
- 25.World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions. Geneve: World Health Organization; 2017. p. 1–11.Google Scholar
- 29.Hopkins H, Hopkins H, Bruxvoort KJ, Cairns ME, Chandler CI, Leurent B, et al. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings. BMJ. 2017;356:11. https://doi.org/10.1136/bmj.j1054.CrossRefGoogle Scholar
- 38.Grandesso F, Nabasumba C, Nyehangane D, Page A-L, Bastard M, De Smet M, et al. Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings. Malar J. 2016;15(1):496. https://doi.org/10.1186/s12936-016-1529-6.CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Kilauzi AL, Mulumba JGT, Magafu MGMD, Matchaba-Hove R, Tapera R, Magafu NS, et al. SD Bioline malaria antigen Pf (HRP-2/pLHD) for assessing efficacy of artemisinin combination therapy against Plasmodium falciparum in pediatric patients in the democratic republic of the Congo. Pan Afr Med J. 2015;22:1–7.CrossRefGoogle Scholar
- 40.Kiemde F, Bonko MDA, Tahita MC, Lompo P, Rouamba T, Tinto H, et al. Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission. Malar J. 2017;16(1):294.CrossRefPubMedPubMedCentralGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.